STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The company operates through three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment, and Dermatology Imaging. Its products include XTRAC laser and VTRAC excimer lamp systems used for the treatment of psoriasis, vitiligo, and other skin conditions; the STRATAPEN MicroSystems, a micropigmentation device; and Nordlys, a multi-technology aesthetic laser device for treating vascular and pigmented lesions. STRATA Skin Sciences, Inc. was founded in 1989 and is based in Horsham, Pennsylvania.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:SSKN
CUSIPN/A
Phone215-619-3200
Debt
Debt-to-Equity Ratio0.35
Current Ratio1.15
Quick Ratio0.81
Price-To-Earnings
Trailing P/E Ratio1.08
Forward P/E Ratio-9.22
P/E GrowthN/A
Sales & Book Value
Annual Sales$31.45 million
Price / Sales0.48
Cash Flow$0.4953 per share
Price / Cash4.28
Book Value$5.46 per share
Price / Book0.39
Profitability
EPS (Most Recent Fiscal Year)$1.97
Net Income$-18,830,000.00
Net Margins-60.23%
Return on Equity-36.19%
Return on Assets-17.75%
Miscellaneous
Employees98
Outstanding Shares7,060,000
Market Cap$14.68 million
STRATA Skin Sciences (NASDAQ:SSKN) Frequently Asked Questions
What is STRATA Skin Sciences' stock symbol?
STRATA Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."
When did STRATA Skin Sciences' stock split? How did STRATA Skin Sciences' stock split work?
STRATA Skin Sciences's stock reverse split on the morning of Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 9th 2014. An investor that had 100 shares of STRATA Skin Sciences stock prior to the reverse split would have 10 shares after the split.
How were STRATA Skin Sciences' earnings last quarter?
STRATA Skin Sciences Inc (NASDAQ:SSKN) posted its quarterly earnings results on Monday, August, 13th. The medical device company reported ($0.02) EPS for the quarter, topping the consensus estimate of ($0.03) by $0.01. The medical device company had revenue of $7.53 million for the quarter, compared to analyst estimates of $6.84 million. STRATA Skin Sciences had a negative net margin of 60.23% and a negative return on equity of 36.19%. View STRATA Skin Sciences' Earnings History.
When is STRATA Skin Sciences' next earnings date?
What price target have analysts set for SSKN?
1 brokerages have issued 1 year target prices for STRATA Skin Sciences' stock. Their predictions range from $3.00 to $3.00. On average, they expect STRATA Skin Sciences' share price to reach $3.00 in the next year. This suggests a possible upside of 41.5% from the stock's current price. View Analyst Price Targets for STRATA Skin Sciences.
What is the consensus analysts' recommendation for STRATA Skin Sciences?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STRATA Skin Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STRATA Skin Sciences.
What are Wall Street analysts saying about STRATA Skin Sciences stock?
Here are some recent quotes from research analysts about STRATA Skin Sciences stock:
- 1. According to Zacks Investment Research, "Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. " (8/1/2018)
- 2. HC Wainwright analysts commented, "We note that PE is typically characterized by damage to he epithelium of the cornea in a pinpoint pattern. Potential causes of PE may include dry eye disease, blepharitis and bacterial conjunctivitis. The number of patients with corneal epitheliopathies in the U.S. could be over 76M, and current therapies have limited efficacy. Investors may recall that OBG is being developed for the acceleration of re-epithelialization of large corneal epithelial defects in patients having undergone photorefractive keratectomy (PRK). EyeGate expects to address the outstanding item cited by the FDA in the IDE for PRK in the current quarter. If so, a clinical trial in PE may start in 2H 2018, according to the management. In our view, the addition of PE could significantly expand the addressable market of OBG. In the wake of this update, we reiterate our Buy rating and $3 price target." (5/31/2018)
Who are some of STRATA Skin Sciences' key competitors?
Some companies that are related to STRATA Skin Sciences include Spectral Medical (EDTXF), Repro-Med Systems (REPR), SANUWAVE Health, Inc. Common Stock (SNWV), iCAD (ICAD), Restoration Robotics (HAIR), Nephros (NEPH), Valeritas (VLRX), Presbia (LENS), Lianluo Smart (LLIT), Obalon Therapeutics (OBLN), Interpace Diagnostics Group (IDXG), Pro-Dex (PDEX), Titan Medical (TMDI), AIT Therapeutics (AITB) and CELLECT BIOTECH/S (APOP).
Who are STRATA Skin Sciences' key executives?
STRATA Skin Sciences' management team includes the folowing people:
- Dr. Dolev Rafaeli, CEO & Director (Age 54)
- Mr. Matthew C. Hill, VP & CFO (Age 49)
- Mr. Jay Sturm, Corp. Counsel & Corp. Sec. (Age 62)
- Keith Simeone, VP of Sales
- Dr. Darrell S. Rigel M.D., Ms, Faad, Chief Medical Advisor (Age 67)
Has STRATA Skin Sciences been receiving favorable news coverage?
News headlines about SSKN stock have trended positive on Monday, according to Accern Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. STRATA Skin Sciences earned a coverage optimism score of 0.48 on Accern's scale. They also gave media coverage about the medical device company an impact score of 46.92 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days. View Recent Headlines for STRATA Skin Sciences.
Who are STRATA Skin Sciences' major shareholders?
STRATA Skin Sciences' stock is owned by a number of of retail and institutional investors. Top institutional investors include Nantahala Capital Management LLC (29.44%), Menora Mivtachim Holdings LTD. (7.86%), Renaissance Technologies LLC (4.16%) and Macquarie Group Ltd. (1.90%). Company insiders that own STRATA Skin Sciences stock include Frank J Mccaney, James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Institutional Ownership Trends for STRATA Skin Sciences.
Which major investors are buying STRATA Skin Sciences stock?
SSKN stock was purchased by a variety of institutional investors in the last quarter, including Nantahala Capital Management LLC, Menora Mivtachim Holdings LTD., Renaissance Technologies LLC and Macquarie Group Ltd.. Company insiders that have bought STRATA Skin Sciences stock in the last two years include Frank J Mccaney, James L Coyne, Luann Via, Matthew C Hill and Samuel E Navarro. View Insider Buying and Selling for STRATA Skin Sciences.
How do I buy shares of STRATA Skin Sciences?
Shares of SSKN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is STRATA Skin Sciences' stock price today?
One share of SSKN stock can currently be purchased for approximately $2.12.
How big of a company is STRATA Skin Sciences?
STRATA Skin Sciences has a market capitalization of $14.68 million and generates $31.45 million in revenue each year. The medical device company earns $-18,830,000.00 in net income (profit) each year or $1.97 on an earnings per share basis. STRATA Skin Sciences employs 98 workers across the globe.
How can I contact STRATA Skin Sciences?
STRATA Skin Sciences' mailing address is 100 LAKESIDE DRIVE SUITE 100, HORSHAM PA, 19044. The medical device company can be reached via phone at 215-619-3200 or via email at [email protected]
MarketBeat Community Rating for STRATA Skin Sciences (NASDAQ SSKN)
MarketBeat's community ratings are surveys of what our community members think about STRATA Skin Sciences and other stocks. Vote "Outperform" if you believe SSKN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SSKN will underperform the S&P 500 over the long term. You may vote once every thirty days.
